Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival

Detalles Bibliográficos
Autores principales: Chin, M, Sive, J I, Allen, C, Roddie, C, Chavda, S J, Smith, D, Blombery, P, Jones, K, Ryland, G L, Popat, R, Rismani, A, D'Sa, S, Rabin, N, Gale, R E, Yong, K L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637106/
https://www.ncbi.nlm.nih.gov/pubmed/29016571
http://dx.doi.org/10.1038/bcj.2017.76
_version_ 1783270571044241408
author Chin, M
Sive, J I
Allen, C
Roddie, C
Chavda, S J
Smith, D
Blombery, P
Jones, K
Ryland, G L
Popat, R
Rismani, A
D'Sa, S
Rabin, N
Gale, R E
Yong, K L
author_facet Chin, M
Sive, J I
Allen, C
Roddie, C
Chavda, S J
Smith, D
Blombery, P
Jones, K
Ryland, G L
Popat, R
Rismani, A
D'Sa, S
Rabin, N
Gale, R E
Yong, K L
author_sort Chin, M
collection PubMed
description
format Online
Article
Text
id pubmed-5637106
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56371062017-10-16 Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival Chin, M Sive, J I Allen, C Roddie, C Chavda, S J Smith, D Blombery, P Jones, K Ryland, G L Popat, R Rismani, A D'Sa, S Rabin, N Gale, R E Yong, K L Blood Cancer J Letter to the Editor Nature Publishing Group 2017-09 2017-09-15 /pmc/articles/PMC5637106/ /pubmed/29016571 http://dx.doi.org/10.1038/bcj.2017.76 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Chin, M
Sive, J I
Allen, C
Roddie, C
Chavda, S J
Smith, D
Blombery, P
Jones, K
Ryland, G L
Popat, R
Rismani, A
D'Sa, S
Rabin, N
Gale, R E
Yong, K L
Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
title Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
title_full Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
title_fullStr Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
title_full_unstemmed Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
title_short Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
title_sort prevalence and timing of tp53 mutations in del(17p) myeloma and effect on survival
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637106/
https://www.ncbi.nlm.nih.gov/pubmed/29016571
http://dx.doi.org/10.1038/bcj.2017.76
work_keys_str_mv AT chinm prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT siveji prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT allenc prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT roddiec prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT chavdasj prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT smithd prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT blomberyp prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT jonesk prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT rylandgl prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT popatr prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT rismania prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT dsas prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT rabinn prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT galere prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival
AT yongkl prevalenceandtimingoftp53mutationsindel17pmyelomaandeffectonsurvival

Ejemplares similares